Muthuswamy Iyer

a) To handle more corporate projects and innovations establishing new contacts. b)Evaluation, cost proposals for the intended projects and cost comparisons presented. c) Networking in the Pharma Industry circle and look for prospective M&A or collaborative partners. d) Life Cycle management of existing portfolio with extended dosage forms evaluation, market supported. e) Support Corporate strategy in Biotech Venture, evaluated Chinese strength in Biosimilars, MAb’s.

a) Introduced companies from India for various projects which involves in reducing time from conceptualization to development program in innovative technologies.b) Tech transfer, custom synthesis, sourcing of API, development of formulations till completion of project. c) Project presentation involving new excipients or novel dosage forms presented with novel ideas d) Handling Audits of manufacturing activity and follow up on compliance issues.

a) Established the concept of “ Outsourcing Services” and engaged business in Contract manufacturing of generics from approved GMP units. b) Handled dossier of Oncology finished formulations to market in EU, Philippines, Venezuela c) Value added services performed by participating in facility Audits and controlling quality . d) Handled and Managed regulatory dossiers, DMF, COS, CTD preparation. e) Concepts established for cost effective manufacturing of products that could be supplied.

a) Strategic sourcing & development of finished dosage forms dossier development for Kamfarma SA, Switzerland (subsidiary of Rivopharm SA Switzerland) b) Handled tender programs and visited Unicef operational sites for technical support and sales c) Performed routine quality checks on the finished dosage goods before despatch from India d) Organised WHO UNICEF rural health medical supplies, out of contract manufacturing from India e) Frequent travelling to Lugano- Principal assignments

Worked in the manufacturing shop floor of Oral solid dosage forms (tablets and capsules) involved in different stages of operations.

Contributed in R&D formulations, Steroidal Facility